CAMBRIDGE NUCLEOMICS

• 72110 - Research and experimental development on biotechnology

Cambridge Nucleomics is a biotech spinoff from the University of Cambridge. We help big pharmas, biotech companies and clinical researchers with a unique value proposition for accurate, fast and direct quantification of native RNA. Our mission is to quantify all short and long RNAs in one simple measurement by 2025, with the vision to build an innovative platform technology company for the RNA era of personalised and precision medicine... Based in Cambridge UK - Cambridge Nucleomics and the Cambridge Nucleomics logo are registered trademarks of the company... With our proprietary nanostructure design technology, we are able to customise molecular probes that recognise specific nucleic acid molecules and detect them natively. Given a target RNA sequence, we design molecular probes that recognise the target. Specific signals from the resulting sample are then "digitised" by using a mature single-molecule readout technique.

Also known as: CAMBRIDGE NUCLEOMICS LTD

Registration numbers: 13135667 (CH)

Primary location: OAKHAM ENGLAND